Barclays’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-600
Closed -$10K 7335
2018
Q1
$10K Buy
+600
New +$10K ﹤0.01% 6663
2017
Q2
Sell
-600
Closed -$8K 6980
2017
Q1
$8K Sell
600
-8,800
-94% -$125K ﹤0.01% 6149
2016
Q4
$150K Buy
9,400
+7,300
+348% +$117K ﹤0.01% 4444
2016
Q3
$35K Buy
2,100
+200
+11% +$2.69K ﹤0.01% 5191
2016
Q2
$21K Hold
1,900
﹤0.01% 5254
2016
Q1
$15K Sell
1,900
-24,700
-93% -$203K ﹤0.01% 5341
2015
Q4
$239K Buy
26,600
+3,400
+15% +$33.9K ﹤0.01% 3766
2015
Q3
$255K Sell
23,200
-1,700
-7% -$20.8K ﹤0.01% 3957
2015
Q2
$299K Buy
24,900
+300
+1% +$3.23K ﹤0.01% 3875
2015
Q1
$221K Sell
24,600
-507,100
-95% -$5.73M ﹤0.01% 4273
2014
Q4
$7.44M Buy
531,700
+527,200
+11,716% +$6.24M 0.01% 1387
2014
Q3
$45K Sell
4,500
-13,900
-76% -$182K ﹤0.01% 5965
2014
Q2
$294K Buy
18,400
+1,600
+10% +$21.3K ﹤0.01% 4458
2014
Q1
$269K Sell
16,800
-141,300
-89% -$2.01M ﹤0.01% 4515
2013
Q4
$1.9M Buy
158,100
+25,900
+20% +$260K ﹤0.01% 2729
2013
Q3
$1.32M Buy
132,200
+126,900
+2,394% +$1.36M ﹤0.01% 3051
2013
Q2
$43K Buy
+5,300
New +$35.7K ﹤0.01% 6408

Other funds holding VNDA